AMT Medical published SAFE-CAB II data in the JTCVS showing ELANA clip-based bypass replacing a hand-sewn technique, reporting a strong safety profile and 92.5% graft patency at six months. The results support incremental clinical benefits from the procedure and may improve investor confidence in the product’s adoption prospects.
AMT Medical published SAFE-CAB II data in the JTCVS showing ELANA clip-based bypass replacing a hand-sewn technique, reporting a strong safety profile and 92.5% graft patency at six months. The results support incremental clinical benefits from the procedure and may improve investor confidence in the product’s adoption prospects.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.35
